Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-09-30

Clinical Trial Update: Impact of Prophylactic Octreotide to Pancreatic Exocrine Secretion [NA]

View source ↗

Summary

A clinical trial update exploring prophylactic octreotide's effect on pancreatic exocrine secretion in periampullary tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: Saint Vincent's Hospital, Korea | Conditions: Periampullary Tumors | NA | Status: UNKNOWN